Art
J-GLOBAL ID：202402291241416092   Reference number：24A0728731

Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma

スタチン療法:肝細胞癌における免疫療法への潜在的アジュバント【JST・京大機械翻訳】
Author (5)：
Wang Jiao

About Wang Jiao

(1Department of Laboratory Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)

About 1Department of Laboratory Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

, 
Liu Chengyu

About Liu Chengyu

(2Department of Transfusion Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)

About 2Department of Transfusion Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

, 
Hu Ronghua

About Hu Ronghua

(2Department of Transfusion Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)

About 2Department of Transfusion Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

, 
Wu Licheng

About Wu Licheng

(3School of Clinical Medicine, Nanchang Medical College, Nanchang, China)

About 3School of Clinical Medicine, Nanchang Medical College, Nanchang, China

, 
Li Chuanzhou

About Li Chuanzhou

(4Department of Medical Genetics, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)

About 4Department of Medical Genetics, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China


Material：
Frontiers in Pharmacology (Web)

About Frontiers in Pharmacology (Web)


Volume： 15  Page： 1324140  Publication year： 2024 
JST Material Number： U7091A  ISSN： 1663-9812  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)
Abstract/Point：
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Hepatocellular carcinoma (HCC)...
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
fatty acid

About fatty acid

,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
切除不能

About 切除不能

,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=24A0728731&from=J-GLOBAL&jstjournalNo=U7091A") }}
Author keywords (6)：
HCC

About HCC

, 
immunotherapy

About immunotherapy

, 
statins

About statins

, 
cholesterol

About cholesterol

, 
ICI

About ICI

, 
inflammation

About inflammation

JST classification (1)：
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for tumors 
(GE03032C)

About Drug therapy(=pharmacotherapy)for tumors

Substance index (2)：
Substance index
Chemical Substance indexed to the Article.
Statine

About Statine

, 
Cholesterol

About Cholesterol

Reference (188)：
  • Abou-AlfaG. K., ChanS. L., KudoM., LauG., KelleyR. K., FuruseJ., et al (2022). Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA. J. Clin. Oncol. 40 (4), 379. doi: 10.1200/JCO.2022.40.4_suppl.379
  • AbraldesJ. G., Rodríguez-VilarruplaA., GrauperaM., ZafraC., García-CalderóH., García-PagánJ. C., et al (2007). Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J. Hepatol. 46 (6), 1040-1046. doi: 10.1016/j.jhep.2007.01.020
  • AbraldesJ. G., VillanuevaC., AracilC., TurnesJ., Hernandez-GuerraM., GenescaJ., et al (2016). Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis. Gastroenterology 150 (5), 1160-1170. doi: 10.1053/j.gastro.2016.01.004
  • AdhyaruB. B., JacobsonT. A. (2018). Safety and efficacy of statin therapy. Nat. Rev. Cardiol. 15 (12), 757-769. doi: 10.1038/s41569-018-0098-5
  • AhernT. P., PedersenL., TarpM., Cronin-FentonD. P., GarneJ. P., SillimanR. A., et al (2011). Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J. Natl. Cancer Inst. 103 (19), 1461-1468. doi: 10.1093/jnci/djr291
ｍore...
Terms in the title (4)：
Terms in the title
Keywords automatically extracted from the title.
スタチン療法

About スタチン療法

, 
肝細胞癌

About 肝細胞癌

, 
免疫療法

About 免疫療法

, 
アジュバント

About アジュバント


Return to Previous Page

TOP

BOTTOM